Glipizide Tablet
Product Images NDC 60505-0141

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 60505-0141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg-500btl.jpg (10mg 500btl)

Label for Glipizide Tablets USP 10 mg, oral tablets in a 500 count bottle. The label includes storage instructions, dosage guidance referring to the package insert, and manufacturer information listing Apotex Inc., Toronto, Ontario, and Apotex Corp., Weston, Florida. The NDC number 60505-0142-2 and a barcode are also visible.*

FDA Label Image

5mg-500btl.jpg (5mg 500btl)

Label for Glipizide Tablets, USP 5 mg oral tablets by Apotex Corp. The label indicates a bottle containing 500 tablets with storage instructions at 20°C to 25°C and note to dispense in a tight, light-resistant container. The label includes the NDC code 60505-0141-2 and manufacturer information for Apotex, Inc.*

FDA Label Image

Glipizide-structure.jpg (Glipizide Structure)

Chemical structure diagram of the active ingredient Glipizide, showing its molecular framework including a pyridine ring, amide linkages, a sulfonyl group, and a cyclohexyl ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.